Israel Englander Charles River Laboratories International, Inc. Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $3.87 Million - $5.05 Million	-20,600 Reduced 66.03%	10,600 $2.09 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $3.08 Million - $4 Million	14,900 Added 91.41%	31,200 $6.45 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $1.28 Million - $1.72 Million	6,300 Added 63.0%	16,300 $4.42 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $2.19 Million - $3.18 Million	-13,300 Reduced 57.08%	10,000 $2.36 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $2.44 Million - $2.8 Million	13,300 Added 133.0%	23,300 $4.9 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $1.92 Million - $2.6 Million	10,000 New	10,000 $2.02 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $474,344 - $651,404	-2,600 Reduced 7.43%	32,400 $6.38 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.